Reuters logo
8 天前
BRIEF-Apellis Pharmaceuticals says ‍closing of a $60 million Series E preferred stock financing
2017年8月10日 / 下午2点15分 / 8 天前

BRIEF-Apellis Pharmaceuticals says ‍closing of a $60 million Series E preferred stock financing

Aug 10 (Reuters) - Apellis Pharmaceuticals Inc

* Closing of a $60 million Series E preferred stock financing led by Sectoral Asset Management​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below